New Chemical Entities (NCEs)

As the world's leading peptide manufacturer, we are currently involved in ~ 150 cGMP projects targeting New Chemical Entities.

Turning Tides Together. A new service in our portfolio is the development and manufacturing of oligonucleotide-based APIs. The technology is applicable to large scale and has strong synergies with peptides.

For New Chemical Entities, Bachem forms project teams with a project manager to coordinate and control the project activities and with team members out of research and development, quality control, quality assurance, regulatory affairs and sales to represent their department within the project. A business development manager is part of the team and addresses your special needs and requirements.

Bachem has close to 50 years of experience in the development, production and filing of peptide and small molecule active pharmaceutical ingredients (APIs). We are looking forward to being part of your project and to supporting you with our capabilities and expertise.

For more information please download our NCE Brochure or contact us below